The Oncology Institute (TOI) Income Statement: Revenue & Earnings

The Oncology Institute Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

The Oncology Institute, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	393.41	324.24	252.48	203.00	187.52
Cost of Revenue	339.42	264.67	200.39	162.16	150.64
Gross Profit	54.00	59.57	52.09	40.85	36.88
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	0.00	113.85	119.69	82.89	41.52
Operating Expenses	114.12	119.72	124.10	86.23	44.70
Operating Income	-60.12	-60.15	-72.01	-45.38	-7.82
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	0.00
Interest Expense	7.50	6.78	-4.08	-0.32	-0.35
Other Income/Expense	-4.55	-16.18	25.90	3.71	-8.72
Income
Income Before Tax	-64.66	-83.10	-0.09	-11.60	-14.82
Income Tax Expense	0.00	-0.04	-0.24	-0.67	-0.49
Net Income	-64.66	-83.07	0.15	-10.93	-14.32
Net Income - Continuous Operations	-64.66	-83.07	0.15	-10.93	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-53.83	-70.45	-67.60	-42.04	-4.65
EBIT	-64.66	-76.33	-72.01	-45.38	-7.82
Depreciation & Amortization	6.29	5.87	4.41	3.34	3.18
Earnings Per Share
Basic EPS	-1.00	-1.00	-	-	-
Diluted EPS	-1.00	-1.00	-	-	-
Basic Shares Outstanding	75.04	73.75	72.79	66.23	59.12
Diluted Shares Outstanding	75.04	73.75	80.61	66.23	59.12